YiChang HEC ChangJiang Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
The dashboard contains a Q&A table on YiChang HEC ChangJiang Pharmaceutical Co Ltd. The analysis of YiChang HEC ChangJiang Pharmaceutical Co Ltd leverages intelligence from across the web and also from public filings by YiChang HEC ChangJiang Pharmaceutical Co Ltd. This ESG assessment for YiChang HEC ChangJiang Pharmaceutical Co Ltd represents the company's reporting of the United Nations Sustainable Development Goals.
YiChang HEC ChangJiang Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 6.4 and governance score of 8.0.
7.5
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
149 | Virbac SA | 7.6 | High |
160 | YiChang HEC ChangJiang Pharmaceutical Co Ltd | 7.5 | High |
160 | C4X Discovery Holdings PLC | 7.5 | High |
160 | Ascentage Pharma Group International | 7.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose current and historical energy intensity?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd report the average age of the workforce?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose cybersecurity risks?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd offer flexible work?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd conduct supply chain audits?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose water use targets?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Did YiChang HEC ChangJiang Pharmaceutical Co Ltd have a product recall in the last two years?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose incidents of discrimination?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has YiChang HEC ChangJiang Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose parental leave metrics?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is YiChang HEC ChangJiang Pharmaceutical Co Ltd involved in embryonic stem cell research?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose its waste policy?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd report according to TCFD requirements?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose energy use targets?
Does YiChang HEC ChangJiang Pharmaceutical Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does YiChang HEC ChangJiang Pharmaceutical Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for YiChang HEC ChangJiang Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, and cardiovascular diseases in the People's Republic of China. It also manufactures and sells active pharmaceutical ingredients; researches and develops medical devices and drugs, as well as biotechnology; and provides medical consulting services. The company sells its products to hospitals and medical institutions through a network of distributors. It has a strategic cooperation framework agreement with Alibaba Health Technology (China) Limited to carry out influenza special projects; Jointown Pharmaceutical Group Co., Ltd.; Guangdong Yihao Pharmaceutical Co., Ltd.; and Shenzhen HEC Industrial Development Co., Ltd, as well as strategic cooperative partnership with China National Accord Medicines Corporation Ltd. The company was formerly known as Yichang Changjiang Pharmaceutical Company Limited and changed its name to YiChang HEC ChangJiang Pharmaceutical Co., Ltd. in May 2015. The company was incorporated in 2001 and is based in Yichang, China. YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a subsidiary of Guangdong HEC Technology Holding Co., Ltd.